Maravai LifeSciences Holdings Inc (MRVI)
8.785
+0.36
(+4.33%)
USD |
NASDAQ |
May 02, 16:00
8.785
0.00 (0.00%)
After-Hours: 19:49
Maravai LifeSciences Holdings Enterprise Value: 1.436B for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 1.436B |
| April 30, 2024 | 1.407B |
| April 29, 2024 | 1.361B |
| April 26, 2024 | 1.341B |
| April 25, 2024 | 1.325B |
| April 24, 2024 | 1.337B |
| April 23, 2024 | 1.344B |
| April 22, 2024 | 1.297B |
| April 19, 2024 | 1.288B |
| April 18, 2024 | 1.329B |
| April 17, 2024 | 1.345B |
| April 16, 2024 | 1.399B |
| April 15, 2024 | 1.395B |
| April 12, 2024 | 1.434B |
| April 11, 2024 | 1.459B |
| April 10, 2024 | 1.460B |
| April 09, 2024 | 1.448B |
| April 08, 2024 | 1.364B |
| April 05, 2024 | 1.374B |
| April 04, 2024 | 1.450B |
| April 03, 2024 | 1.461B |
| April 02, 2024 | 1.448B |
| April 01, 2024 | 1.460B |
| March 28, 2024 | 1.469B |
| March 27, 2024 | 1.457B |
| Date | Value |
|---|---|
| March 26, 2024 | 1.426B |
| March 25, 2024 | 1.446B |
| March 22, 2024 | 1.481B |
| March 21, 2024 | 1.402B |
| March 20, 2024 | 1.406B |
| March 19, 2024 | 1.383B |
| March 18, 2024 | 1.375B |
| March 15, 2024 | 1.341B |
| March 14, 2024 | 1.289B |
| March 13, 2024 | 1.368B |
| March 12, 2024 | 1.346B |
| March 11, 2024 | 1.348B |
| March 08, 2024 | 1.337B |
| March 07, 2024 | 1.274B |
| March 06, 2024 | 1.286B |
| March 05, 2024 | 1.263B |
| March 04, 2024 | 1.329B |
| March 01, 2024 | 1.327B |
| February 29, 2024 | 1.345B |
| February 28, 2024 | 1.383B |
| February 27, 2024 | 1.415B |
| February 26, 2024 | 1.385B |
| February 23, 2024 | 1.428B |
| February 22, 2024 | 998.40M |
| February 21, 2024 | 1.018B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
939.63M
Minimum
Nov 08 2023
7.229B
Maximum
Aug 20 2021
3.270B
Average
3.095B
Median
Enterprise Value Benchmarks
| ModivCare Inc | 1.411B |
| Dyadic International Inc | 35.33M |
| Enveric Biosciences Inc | 4.494M |
| Monopar Therapeutics Inc | 4.080M |
| SeaStar Medical Holding Corp | 44.31M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -105.96M |
| Revenue (Quarterly) | 74.14M |
| Total Expenses (Quarterly) | 78.18M |
| EPS Diluted (Quarterly) | -0.80 |
| Gross Profit Margin (Quarterly) | 52.65% |
| Profit Margin (Quarterly) | -142.9% |
| Earnings Yield | -10.25% |
| Normalized Earnings Yield | -55.59 |